Mak", form your post:but when I spoke to them fairly recently,...

Mak", form your post:

but when I spoke to them fairly recently, the plan was to begin a short single-dose, followed by multi-dose trial in December, however, more likely if closer to Christmas that this would begin early January instead. Phase 3 trials still on track to begin 1st quarter 2012 but I wouldn't be surprised if it's pushed back to Q2"

I do not believe that this information has been publically announced. It sounds like there is nothing happening before the new year?

I may have missed an announcement, if so my apologies.

And, KC, I agree that the term "dormant" is perhaps too harsh, however I was referring to the company's ability to update its shareholders on OXY, not what is happening in the lab in Clayton or the office in New York. There is no doubt that the white coats and bunsen burners are going flat chat!